Prostate cancer Posts - Page 23 of 80 on Medivizor
Navigation Menu

Prostate cancer Posts on Medivizor

ASCO’s National Cancer Opinion Survey Results

ASCO’s National Cancer Opinion Survey Results

Posted by on Jan 24, 2019 in Blog, Breast cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer |

During July and early August of  2018, the Harris Poll in association with the American Society of Clinical Oncologists (ASCO’s) conducted a poll of 4,887 U.S. adults, 1001 of these have or had cancer. This second annual National Cancer Opinion Survey explored a wide range of topics. The findings clearly describe disparities in the care patients with...

Read More

Looking for men with prostate cancer, resistant to male hormone suppression, to be treated with medication and radiotherapy

Looking for men with prostate cancer, resistant to male hormone suppression, to be treated with medication and radiotherapy

Posted by on Jan 20, 2019 in Prostate cancer | 0 comments

In a nutshell This study evaluates the effectiveness of medication and focal radiation in the treatment of prostate cancer resistant male hormone suppression. The main outcome to be measured in this trial is the number of patients whose cancer does not grow or spread and who are alive at 18 months after treatment. This trial is taking place in Ann...

Read More

Is obesity connected to prostate cancer recurrence?

Is obesity connected to prostate cancer recurrence?

Posted by on Jan 18, 2019 in Prostate cancer | 0 comments

In a nutshell This study looked at if body mass index (BMI) is connected to possible prostate cancer recurrence. It concluded that there is an association between higher BMI and possible prostate cancer recurrence. It also concluded that obese men did not have more aggressive cancer recurrences.  Some background Prostate cancer is cancer that...

Read More

What is the optimal timing of exercise therapy for men taking androgen deprivation therapy?

What is the optimal timing of exercise therapy for men taking androgen deprivation therapy?

Posted by on Jan 5, 2019 in Prostate cancer | 0 comments

In a nutshell This study aimed to examine the timing of exercise therapy in patients with prostate cancer taking androgen deprivation therapy (ADT). This study found that starting exercise at the onset of ADT helps preserve muscle mass and bone density.  Some background Androgen deprivation therapy (ADT) is a treatment option in...

Read More

Long term results discussing radiotherapy and hormone therapy treatments for patients with prostate cancer

Posted by on Dec 16, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to evaluate whole pelvic radiotherapy (WPRT) compared to prostate only radiotherapy (PORT) with hormonal therapy (HT) before or after radiation for patients with intermediate- or high-risk prostate cancer. This study found that HT before radiotherapy and WPRT had superior long-term survival without cancer growing or...

Read More

Comparing robot-assisted laparoscopic prostate surgery versus open prostate surgery

Posted by on Dec 11, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to compare traditional open surgery and robotic surgery to treat prostate cancer in terms of side effects. It found that there was no difference in side-effects like sexual function or urinary problems between the two surgeries. Some background Prostate surgery is a treatment option for prostate cancer. This surgery...

Read More

Searching for patients with castration resistant metastatic prostate cancer to test cabazitaxel and abiraterone

Posted by on Dec 10, 2018 in Prostate cancer | 0 comments

In a nutshell This trial is examining the safety and effectiveness of cabazitaxel (Jevtana) with abiraterone acetate (Zytiga) compared to abiraterone acetate alone for metastatic (cancer that has spread) castration-resistant prostate cancer (cancer that is no longer responding to hormone therapy). The main outcome measured will be the...

Read More

Apalutamide does not affect health-related quality of life in patients with localized prostate cancer

Apalutamide does not affect health-related quality of life in patients with localized prostate cancer

Posted by on Nov 28, 2018 in Prostate cancer | 0 comments

In a nutshell This study investigated the effect of apalutamide (Erleada) on health-related quality of life (H-QoL) in patients with prostate cancer. This study found that apalutimide preserved H-QoL while prolonging time taken for cancer to spread.  Some background One treatment option for patients with prostate cancer is androgen...

Read More

Is conventional or hypofractionated radiation therapy better for the treatment of prostate cancer?

Is conventional or hypofractionated radiation therapy better for the treatment of prostate cancer?

Posted by on Nov 26, 2018 in Prostate cancer | 0 comments

In a nutshell This study compared two different types of radiation therapy after prostate surgery for prostate cancer, hypofractionated postprostatectomy radiation therapy (hypoPORT) and conventional postprostatectomy radiation therapy (coPORT). Results showed that hypoPORT may be effective in prostate cancer control and with similar side effects as...

Read More